Drug Discovery & DDS Weekly Report May 31, 2026

Regulatory & Policy Shifts Reshape Global Biologics Manufacturing Strategy: Focus on EU Reform, UK Decentralization, and US Tariffs

US Department of Veterans Affairs Launches MDMA-Assisted Mental Health Therapy Trial

WuXi Biologics Intensifies Focus on South Korea to Bolster K-Biotech Partnerships Amid US Pressure

WuXi Biologics Shanghai Drug Product Facility Achieves GMP Release, Expands Global Capacity

FDA Approves Hepcludex, First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection

Tuning siRNA Packing Order in Lipid Nanoparticles Controls Oligonucleotide Functional Delivery

Insilico Medicine and Saudi Aramco Unveil ‘Sanity Pipeline’ for AI-Driven MOF Discovery

CVS Caremark Expands Access to Eli Lilly’s Obesity Portfolio: Reinstates Zepbound, Adds Foundayo